Novacyt S.A. (NVYTF)
OTCMKTS · Delayed Price · Currency is USD
0.5514
+0.0134 (2.49%)
At close: Jul 7, 2025
Novacyt Market Cap
Novacyt has a market cap or net worth of $37.09 million as of August 1, 2025. Its market cap has decreased by -10.17% in one year.
Market Cap
37.09M
Enterprise Value
10.90M
Revenue
24.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.55
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 30.50M to 37.09M, an increase of 21.61%. That is a compound annual growth rate of 1.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 37.09M | -15.65% |
| Dec 31, 2024 | 43.97M | -20.95% |
| Dec 29, 2023 | 55.62M | -40.03% |
| Dec 30, 2022 | 92.74M | -73.63% |
| Dec 31, 2021 | 351.75M | -58.45% |
| Dec 31, 2020 | 846.58M | 7,591.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |